MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
common stock warrant...
-$5,845K
Other income, net
$1,101K
Net loss and
comprehensive loss
-$35,036K
Total other income,
net
$6,946K
Loss from operations
-$41,982K
Total revenue
$43,766K
Total operating
expenses
$85,748K
Research and development
$56,039K
General and
administrative
$29,709K
Back
Back
Income Statement
source: myfinsight.com
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)